Liminatus Pharma LIMN
NASDAQ LIMN
$3.96 +0.05 (+1.28%)
As of: Sep 30, 2026 · 2:05 PM EDT

Liminatus Pharma, Inc. (LIMN) Total Non-Current Liabilities (2025 - 2026)

Updated

Liminatus Pharma (LIMN) reported Total Non-Current Liabilities of $3.04 million for Q2 2026, down 71.1% from $10.52 million a year earlier but up 5.2% from the prior quarter.

Analysis

Liminatus Pharma, Inc. (LIMN) Total Non-Current Liabilities (2025 - 2026) Analysis & Trends

At the end of FY2025, Liminatus Pharma posted Total Non-Current Liabilities of $10.3 million.

  • Five-year quarterly Total Non-Current Liabilities spans a low of $2.86 million in Q3 2025 and a high of $10.52 million in Q2 2025.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $2.89 million (Q1 2026), $10.3 million (Q4 2025) and $2.86 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.04 Mn
Mar 31, 2026 2.89 Mn
Dec 31, 2025 10.30 Mn
Sep 30, 2025 2.86 Mn
Jun 30, 2025 10.52 Mn
API Access

Liminatus Pharma, Inc. Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=LIMN&period=max&api_key=YOUR_API_KEY